Quantitative immunohistochemical assessment of clinically non-functioning pituitary adenomas
Abstract
Introduction. Immunohistochemical staining is currently the gold standard of diagnostic and classification of pituitary adenomas. However, there are some discrepancies between immunohistochemical staining results and the clinical picture of pituitary adenomas. Pituitary adenomas with positive immunohistochemical reaction might not cause any endocrinological symptoms or changes in serum pituitary hormone levels. Such a discordance may be caused partly by clinically non-functioning pituitary adenomas (CNFPAs). The aim of our study was to establish the frequency of CNFPAs and identify their histological types using quantitative immunohistochemical assessment.
Materials and methods. We enrolled in the study 72 patients with pituitary adenoma, and their medical history was evaluated retrospectively. The immunohistochemical panel of anterior pituitary hormones was introduced in all cases. The immunoreactivity index was calculated manually for each specimen. Results. 36.1% patients of the evaluated group presented as CNFPAs. Among the CNFPA patients we found 38.46% cases with positive immunohistochemical reaction for one or more anterior pituitary lobe hormones. In 23.07% of cases the adenomas were monohormonal, and in 15.38% they were plurihormonal.
Conclusions. The morphometric method utilising the immunoexpression index introduced in this study provided a very precise recognition of pituitary adenoma pathology. In the case of CNFPAs the immuno-histochemical staining often reveals a positive reaction also for multiple pituitary hormones. Quantitative assessment limits the subjectivity of the examiner and allows objective results comparison, so it should become a standard in histopathological assessment of pituitary adenomas.
Keywords: non-functioning pituitary adenomaimmunoreactivity indexquantitative evaluationimmuno-histochemical staining
References
- Lloyd RV, Kovacs K, Young Jr. Pituitary tumors: Introduction. In: Delellis RA, Lloyd RV, Heitz PU, Eng C. ed. World Health Organisation Classification of Tumours: Pathology & Genetics – Tumours of Endocrine Organs. IARC Press, Lyon 2004: 10–13.
- Faglia G. Epidemiology and pathogenesis of pituitary adenomas. Acta Endocrinol. 1993; 129(Suppl 1): 1–5.
- Kontogeorgos G. Classification and pathology of pituitary tumors. Endocrine. 2005; 28(1): 27–35.
- Korali Z, Müller A, Schopohl J. Hypophysentumoren und Kraniopharyngeome. . In: Manual – Hirntumoren und primäre Tumoren des Rückenmarks. Tumorzentrum München, München 2001: 89–108.
- Scheithauer B, Kovacs K, Horvath E, et al. Pathology of the pituitary and Sellar Region. Practical Surgical Neuropathology. 2010: 371–416.
- Kontogeorgos G, Watson Jr, Lindell EP. Growth hormone producing adenoma. . In: Delellis RA, Lloyd RV, Heitz PU, Eng C. ed. World Health Organisation Classification of Tumours: Pathology & Genetics – Tumours of Endocrine Organs. IARC Press, Lyon 2004: 14–19.
- Trouillas J, Barkan AL, Watson JRE. ACTH producing adenoma. . In: Delellis RA, Lloyd RV, Heitz PU, Eng C. ed. World Health Organisation Classification of Tumours: Pathology & Genetics – Tumours of Endocrine Organs. IARC Press, Lyon 2004: 25–29.
- Osamura RY, Sano T, Ezzat S. TSH producing adenoma. . In: Delellis RA, Lloyd RV, Heitz PU, Eng C. ed. World Health Organisation Classification of Tumours: Pathology & Genetics – Tumours of Endocrine Organs. IARC Press, Lyon 2004: 24–25.
- Yamada S, Ohyama K, Taguchi M, et al. A study of the correlation between morphological findings and biological activities in clinically nonfunctioning pituitary adenomas. Neurosurgery. 2007; 61(3): 580–4; discussion 584.
- Arafah BM, Prunty D, Ybarra J, et al. The dominant role of increased intrasellar pressure in the pathogenesis of hypopituitarism, hyperprolactinemia, and headaches in patients with pituitary adenomas. J Clin Endocrinol Metab. 2000; 85(5): 1789–1793.
- Gondim JA, Tella OI, Schops M. Intrasellar pressure and tumor volume in pituitary tumor: relation study. Arq Neuropsiquiatr. 2006; 64(4): 971–975.
- Levy MJ, Matharu MS, Meeran K, et al. The clinical characteristics of headache in patients with pituitary tumours. Brain. 2005; 128(Pt 8): 1921–1930.
- Mahta A, Haghpanah V, Lashkari A, et al. Non-functioning pituitary adenoma: immunohistochemical analysis of 85 cases. Folia Neuropathol. 2007; 45(2): 72–77.
- Saeger W, Lüdecke DK, Buchfelder M, et al. Pathohistological classification of pituitary tumors: 10 years of experience with the German Pituitary Tumor Registry. Eur J Endocrinol. 2007; 156(2): 203–216.
- Fahlbusch R, Buslei R. The WHO classification of pituitary tumours: a combined neurosurgical and neuropathological view. Acta Neuropathol. 2006; 111(1): 86–87.
- Hamid Z, Mrak R, Ijaz M, et al. Sensitivity and specificity of immunohistochemistry in pituitary adenomas. The Endocrinologist. 2009; 19(1): 38–43.
- Ho DM, Hsu CY, Ting LT, et al. Plurihormonal pituitary adenomas: immunostaining of all pituitary hormones is mandatory for correct classification. Histopathology. 2001; 39(3): 310–319.
- Sung-Ku P, Shin J, Tae-Young J, et al. Correlation of clinical and immunohistochemical diagnosis in patients with pituitary adenomas. J Korean Neurosurg Soc. 2007; 41: 367–370.
- Herzog T, Schlote W, Lorenz R, et al. Pituitary adenomas: serum hormone levels and immunohistochemical staining for ACTH, GH and prolactin. Clin Neuropathol. 1993; 12(2): 117–120.
- Pawlikowski M, Kunert-Radek J, Radek M. Plurihormonality of pituitary adenomas in light of immunohistochemical studies. Endokrynol Pol. 2010; 61(1): 63–66.
- Sen O, Ertorer ME, Aydin MV, et al. Silent pituitary macroadenoma co-secreting growth hormone and thyroid stimulating hormone. J Clin Neurosci. 2005; 12(3): 318–320.
- Zhao D, Tomono Y, Tsuboi K, et al. Immunohistochemical and ultrastructural study of clinically nonfunctioning pituitary adenomas. Neurol Med Chir (Tokyo). 2000; 40(9): 453–6; discussion 456.
- Destrieux C, Kakou MK, Velut S, et al. Microanatomy of the hypophyseal fossa boundaries. J Neurosurg. 1998; 88(4): 743–752.
- DI CHIRO G, NELSON KB. The volume of the sella turcica. Am J Roentgenol Radium Ther Nucl Med. 1962; 87: 989–1008.
- Knosp E, Krisch K, Schmidbauer M, et al. Immunologischer Hormonnachweis bei Hypophysenadenomen: Korrelation von Serumhormonbefunden mit immunzytochemischem Hormonbefund am Tumorschnitt. Wien Klin Wochenschr. 1988; 100: 322–325.
- Asa SL, Ezzat S, Watson JRE. Gonadotropin producing adenoma. I. In: Delellis RA, Lloyd RV, Heitz PU, Eng C. ed. World Health Organisation Classification of Tumours: Pathology & Genetics – Tumours of Endocrine Organs. IARC Press, Lyon 2004: 30–32.
- Gsponer J, De Tribolet N, Déruaz JP, et al. Diagnosis, treatment, and outcome of pituitary tumors and other abnormal intrasellar masses. Retrospective analysis of 353 patients. Medicine (Baltimore). 1999; 78(4): 236–269.
- Maksymowicz M. Ocena przydatności mikroskopii elektronowej i immunocytochemii na poziomie ultrastrukturalnym w diagnostyce klasyfikacji gruczolaków przysadki [dissertation]. Medical University of Warsaw, 2005.
- Bieniecki W, Sekulska J. Segmentacja i analiza obrazów mikroskopowych barwionych immunohistochemicznie. Automatyka. 2003; 7: 283–293.